Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease.

Scientific reports·2020
Same author

An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.

The EMBO journal·2020
Same author

Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression.

Nature·2020
Same author

Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver.

Nature protocols·2020
Same author

Translation and Replication Dynamics of Single RNA Viruses.

Cell·2020
Same author

CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids.

Cell stem cell·2020
Same journal

Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers.

Trends in cancer·2026
Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026
Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026
Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026
Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026
Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers
08:13

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

10.8K

Human-Derived Model Systems in Gynecological Cancer Research.

Kadi Lõhmussaar1, Matteo Boretto1, Hans Clevers1

  • 1Hubrecht Institute, Royal Netherlands Academy of Art and Sciences and University Medical Center Utrecht, Uppsalalaan 8, 3584CM Utrecht, The Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584CG, Utrecht, The Netherlands.

Trends in Cancer
|August 29, 2020
PubMed
Summary
This summary is machine-generated.

Developing reliable human-derived models is crucial for understanding gynecological cancers, including ovarian, endometrial, cervical, vaginal, and vulvar cancers, and advancing personalized therapies.

Keywords:
cancer modelinggynecologyhuman papillomavirusorganoids

More Related Videos

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

11.2K
Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.3K

Related Experiment Videos

Last Updated: Dec 10, 2025

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers
08:13

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

10.8K
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

11.2K
Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.3K

Area of Science:

  • Gynecological oncology
  • Reproductive biology
  • Cancer modeling

Background:

  • The human female reproductive tract (FRT) comprises diverse organs (ovaries, fallopian tubes, uterus, cervix, vagina, vulva) with unique cellular properties.
  • This anatomical and cellular diversity contributes to the development of various epithelial gynecological cancers with distinct pathological features.
  • Understanding the regional pathogenesis of these cancers necessitates reliable experimental systems.

Purpose of the Study:

  • To review existing human-derived model systems for studying gynecological cancers.
  • To highlight recent advancements in the development of personalized therapeutic strategies for these cancers.
  • To provide a comprehensive overview of models for ovarian, endometrial, cervical, vaginal, and vulvar cancers.

Main Methods:

  • Literature review of human-derived model systems.
  • Analysis of current research on gynecological cancer pathogenesis.
  • Examination of progress in personalized medicine approaches for FRT cancers.

Main Results:

  • Identification and categorization of various human-derived models (e.g., cell lines, organoids, patient-derived xenografts) applicable to FRT cancers.
  • Discussion of the strengths and limitations of each model system in recapitulating disease heterogeneity.
  • Overview of emerging trends and technologies in gynecological cancer research.

Conclusions:

  • Human-derived models are essential for elucidating the complex mechanisms underlying gynecological cancer development and progression.
  • Continued development and application of these models are critical for advancing personalized treatment strategies.
  • This review provides a valuable resource for researchers investigating FRT cancers and seeking effective therapeutic interventions.